Morgan Keegan Maintains Outperform on Brookdale Senior Living

Morgan Keegan is out with its report today on Brookdale Senior Living BKD, maintaining Outperform. In its report, Morgan Keegan writes, "While we view Brookdale shares as cheap, we believe they may remain so for a few months, given two downward revisions to guidance and the impact of new economic uncertainty on operations. We believe that long-term prospects remain strong, though the near term may be lackluster." Morgan Keegan maintains a $21 PT on BKD. Shares of BKD closed Friday at $15.34, down 3.34% from Thursday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!